Predicting "real world" effectiveness by integrating adherence with pharmacodynamic modeling.
Hughes
Dyfrig A
DA
Department of Pharmacology and Therapeutics, University of Liverpool, United Kingdom. dyfrig@liv.ac.uk
Walley
Tom
T
D008078:Cholesterol, LDL / Q000097:blood*; D016001:Confidence Intervals; D005544:Forecasting; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008954:Models, Biological; D010349:Patient Compliance / Q000706:statistics & numerical data*
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors